Food | Page 136 of 210 | SpiritIndia.com

Infant :: Olympic Cool-Cap system reduces Brain Damage in Infants

The Food and Drug Administration (FDA) today approved a first-of-a-kind medical device for the treatment of babies born with moderate to severe hypoxic-ischemic encephalopathy (HIE), a potentially fatal injury to the brain caused by low levels of oxygen.

Ulcerative Colitis :: Salix’ Colazal, balsalazide disodium for Active Ulcerative Colitis

The Food and Drug Administration (FDA) today approved Colazal (balsalazide disodium) for the treatment of mildly to moderately active ulcerative colitis in patients 5 to 17 years of age.

Salmonella :: Practice Egg Safety this Holiday Season to avoid foodborne illness

The U. S. Food and Drug Administration (FDA) reminds consumers to pay special attention to the handling of eggs and preparation of foods that contain eggs during this holiday season.

Obesity :: Common microbes living in the gut contribute to obesity

A link between obesity and the microbial communities living in our guts is suggested by new research at Washington University School of Medicine in St. Louis. The findings indicate that our gut microbes are biomarkers, mediators and potential therapeutic targets in the war against the worldwide obesity epidemic.

Restless Legs Syndrome :: Requip, ropinirole treatment for restless legs syndrome

Newly approved medications for restless leg syndrome may only be effective for a time, suggest movement disorder neurologists from the University of Rochester Medical Center. If taken too long, in some cases the drugs can actually backfire, causing symptoms to worsen. Rochester specials suggest that treatment that rotates through different types of medications may be needed for many patients.

Systemic Lupus Erythematosus :: Safety concern regarding Rituxan in systemic lupus erythematosus

The Food and Drug Administration (FDA) is alerting health care professionals and patients treated with Rituxan (rituximab) to reports of an emerging risk of a serious side effect in patients receiving or who have used Rituxan.

Pain :: FDA amends labeling changes to OTC Pain Relievers

The Food and Drug Administration (FDA) today proposed to amend the labeling regulations on over-the-counter (OTC) Internal Analgesic, Antipyretic, and Antirheumatic (IAAA) drug products to include important safety information regarding the potential for stomach bleeding and liver damage and when to consult a doctor. OTC IAAA drug products, commonly known as acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin, ibuprofen, naproxen and ketoprofen, are used to treat pain, fever, headaches, and muscle aches.

Diet :: Food Safety Tips for Christmas

Christmas is a great time to bring family and friends together, but a risky period for food poisoning, the Parliamentary Secretary for Health and Ageing, Christopher Pyne, said today.

Brain :: Deal or no deal – Need for immediate reward linked to more active brain region

How people might play the popular game show — whether they’d accept an offer for quick cash or hold out for the chance to win $1 million — probably has less to do with what?s inside each briefcase than what’s inside each contestant’s brain, suggests a study. While researchers didn’t study players of the game, their research in normal adults provides new insight about reward-based decision making and may have implications for understanding and treating addiction.

Norovirus :: Norovirus in Olive Garden food illness outbreak – Indianapolis

Marion County Health Department confirms norovirus highly contagious virus for an outbreak of illness among nearly 400 customers of an Olive Garden restaurant outside Indianapolis. Tests on three employees and one customer were positive for norovirus.